0685 Sleep Problems and Solutions in Perimenopausal and Menopausal Women. (12th April 2019)

• Record Type: Journal Article
• Authors: Walters, Russel M; Composto, Jordana; Leichman, Erin S; Mindell, Jodi A
• Is Part Of: Sleep. Volume 42(2019)Supplement 1
• Page Start: A274
• Page End: A274
• Publication Date: 2019-04-12
• Subjects: Sleep -- Physiological aspects -- Periodicals; Sleep disorders -- Periodicals; Sommeil -- Aspect physiologique -- Périodiques; Sommeil, Troubles du -- Périodiques; Sleep disorders; Sleep -- Physiological aspects; Sleep -- physiological aspects; Sleep Wake Disorders; Psychophysiology; Electronic journals; Periodicals; 616.8498
• DOI: 10.1093/sleep/zsz067.683
• Languages: English
• ISSNs: 0161-8105

Abstract

Abstract: Introduction: The aim of this study was to explore sleep problems and sleep medication usage in perimenopausal and menopausal women. Methods: 2, 793 women (1, 145 of perimenopausal and menopausal age, 45-60 years; 1, 648, ages <44 and >60 years), recruited through social media, completed a comprehensive online sleep assessment modified for mobile experience, including the Insomnia Severity Index (ISI), Epworth Sleepiness Scale (ESS), anxiety GAD-7, and questions about attempted sleep solutions. Results: Women in the perimenopausal and menopausal age range had significantly higher ISI (16.3 vs 15.3, p<0.001) and ESS scores than other women (9.1 vs 8.5, p<.001). Anxiety significantly decreased continuously with age, but was not associated with menopausal age group. Women reported that hot flashes disrupted their sleep more frequently in the perimenopause and menopause age group (27% vs 13%). Women of perimenopause and menopause age who experienced hot flashes also reported higher rates of OTC sleeping medication (not including melatonin) current usage 27% compared to women who did not experience hot flashes (20%) and 19% in women in other age groups. Melatonin (43% vs 34% vs 33%) and prescription sleeping medication usage (26% vs 17% vs 16%) had a similar pattern. Conclusion: Perimenopausal or menopausal women are a unique segment with significantly higher rates of both insomnia and daytime sleepiness. Hot flashes are a common disrupter of sleep, and result in higher use of over the counter and prescription sleeping medication use. Targeted recommendations specific to this unique population are required. Support (If Any): Johnson & Johnson Consumer Inc., Skillman, NJ, USA. Somn Labs, Philadelphia, PA, USA